+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of aggressive B-cell-non-Hodgkin lymphoma patients according to the German B-ALL protocol



Treatment of aggressive B-cell-non-Hodgkin lymphoma patients according to the German B-ALL protocol



Onkologie 23(Sonderheft 7): 149




(PDF emailed within 1 workday: $29.90)

Accession: 035980886

Download citation: RISBibTeXText


Related references

Aggressive treatment of b cell non hodgkin lymphoma a protocol of the french pediatric oncology society preliminary results on 60 patients. European Journal Of Cancer & Clinical Oncology: 1052, 1982

CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group. Annals of Oncology 23(5): 1267-1273, 2012

Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Annals of Oncology 19(3): 545-552, 2007

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group. Blood 116(18): 3418-3425, 2010

Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol. Srpski Arhiv Za Celokupno Lekarstvo 126(9-10): 345-348, 1998

Bendamustine as first-line treatment in patients with advanced indolent non-Hodgkin lymphoma and mantle cell lymphoma in German routine clinical practice. Annals of Hematology 94(9): 1553-1558, 2015

Prognostic value of positron emission tomography (PET) scan in patients with relapsed Hodgkin lymphoma or aggressive Non-Hodgkin lymphoma receiving salvage chemotherapy followed by reduced-intensity allogeneic stem cell transplantation. 2007

New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group. Journal of Clinical Oncology 20(1): 221-230, 2002

Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Annals of Oncology 14(6): 881-893, 2003

Hematopoietic stem cell transplantation as salvage treatment in patients with aggressive non-Hodgkin's lymphoma. Medicina Clinica 114(4): 128-131, 2000

Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantation. Cancer 116(21): 5001-5011, 2010

CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Blood 113(17): 3896-3902, 2009

Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Annals of Oncology 18(1): 149-157, 2006

Cell cycle characteristics and Epstein-Barr virus are differentially associated with aggressive and non-aggressive subsets of Hodgkin lymphoma in pediatric patients. Leukemia and Lymphoma 51(8): 1513-1522, 2010

Radioimmunotherapy for first-line and relapse treatment of aggressive B-cell non-Hodgkin lymphoma: an analysis of 215 patients registered in the international RIT-Network. European Journal of Nuclear Medicine and Molecular Imaging 41(8): 1585-1592, 2015